Innovations in Immunology
GeoVax is a clinical-stage biotechnology company developing human vaccines and immunotherapies to address unmet medical needs in cancer and infectious disease.
Our current development programs are focused on preventive vaccines against COVID-19, hemorrhagic fever viruses (Ebola, Lassa, Marburg and Sudan), Zika Virus, HIV and malaria, as well as therapeutic vaccines against multiple cancers.
